openPR Logo
Press release

Preimplantation Genetic Diagnosis Market (PGD) to Reach $121.50 Million, Globally, by 2022 with key players . Hoffmann-La Roche AG, Reprogenetics, LLC, Genea Limited, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, I

10-09-2018 07:51 PM CET | Health & Medicine

Press release from: Allied Market Research

Preimplantation Genetic Diagnosis Market (PGD) to Reach

Preimplantation Genetics Diagnosis Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $121 million by 2022, registering a CAGR of 6.14% during the period 2016-2022.

Access Full Summary at : https://www.alliedmarketresearch.com/preimplantation-genetic-diagnosis-market

Around 30 to 60% of the human embryos have chromosomal abnormalities. They usually occur in women aged 40 and above. Moreover, chromosomal abnormalities are also seen in working women due to the hectic lifestyle patterns which increase the demand of various diagnostic procedures including PGD.

Get sample copy of this report at:
https://www.alliedmarketresearch.com/request-sample/1470

Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Geographically, Europe holds the highest potential to generate major revenue of the global market accounting for about 31.8% share in 2015. While Asia-Pacific is the fastest growing region registering a CAGR of 6.7%.

Key Findings of Preimplantation Genetics Diagnosis Market Study:

• Around 30% to 60% of the human embryos have chromosomal abnormalities. Chromosomal abnormalities in the embryo are usually occurs in the women aged 40 or over.

• Almost 33% of the top strategies were merger and acquisition; whereas, business expansion, partnership and product launch accounted for 25%, 22.22% and 19.44% respectively of the overall key strategies.

• Pricing of PGD tests is expected to witness a decline with increase in the volume of PGD testing

• Chromosomal Abnormalities test generates the largest share in terms of revenue for PGD market

• HLA Typing and Gender Selection based tests are the two fastest growing segments within Preimplantation Genetics Diagnosis market.

Get customized copy of this report at:
https://www.alliedmarketresearch.com/request-for-customization/1470

Key players :

• F. Hoffmann-La Roche AG
• Reprogenetics LLC
• Genea Limited
• Illumina Inc.
• Laboratory Corporation of America Holdings
• Natera Inc.
• PerkinElmer Inc.
• Quest Diagnostics Incorporated
• Genesis Genetics Ltd.
• Reproductive Genetics Innovations LLC.

Table of content:


Chapter: 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments:
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factor
3.2.2 Top winning strategies
3.2.3 Top investment pockets

3.3 Porters five forces analysis

3.3.1 Low bargaining power of suppliers due to large number of suppliers and moderate switching cost
3.3.2 Moderate bargaining power of buyers due to large number of buyers, high product dependency and moderate switching cost.
3.3.3 Moderate threat of substitutes due to ease of substitution, moderate price war and high brand loyalty
3.3.4 Low threat of new entrants due to presence of dominant players and high investment cost and legal barriers
3.3.5 Presence of numerous players, high growth rate and high economic base increases the competition among rivalries

3.4 Drivers

3.4.1 Effective solution for the healthy embryos
3.4.2 Increasing infertility rate and genetic, hereditary and chromosomal diseases
3.4.3 Innovative and wide range of applications such as development of savior siblings and gender selection among others

3.5 Restraints

3.5.1 Stringent regulations and ethical concerns
3.5.2 High cost incurred and risk involved in PGD

3.6 Opportunities

3.6.1 Increasing adoption of PGD in developing countries

Get full summary of this report at:
https://www.alliedmarketresearch.com/preimplantation-genetic-diagnosis-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preimplantation Genetic Diagnosis Market (PGD) to Reach $121.50 Million, Globally, by 2022 with key players . Hoffmann-La Roche AG, Reprogenetics, LLC, Genea Limited, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, I here

News-ID: 1291802 • Views:

More Releases from Allied Market Research

3D Printing Filament Market Comprehensive Growth Outlook and Trend Analysis, 2024-2031
3D Printing Filament Market Comprehensive Growth Outlook and Trend Analysis, 202 …
According to the report, the global 3D printing filament market was valued at $0.9 billion in 2023 and is projected to reach $2.3 billion by 2031, registering a CAGR of 12.8% from 2024 to 2031. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/3d-printing-filament-market-A11572 Key Growth Drivers: The growth of the 3D printing filament market is fueled by continuous advancements in filament materials-such as carbon fiber-reinforced composites, metal-infused filaments, and high-performance engineering plastics. These innovations
Wet Chemicals Market Detailed Analysis, Growth Trends, and Future Outlook 2025-2031
Wet Chemicals Market Detailed Analysis, Growth Trends, and Future Outlook 2025-2 …
According to a recent report by Allied Market Research (AMR), the global wet chemicals market is poised for substantial growth, projected to reach a value of $5.9 billion by 2031, up from $3.2 billion in 2021. This comprehensive analysis explores market dynamics, growth drivers, and strategic initiatives while highlighting key opportunities across regions and industry segments. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A17425 The study delves into development trends, investment frameworks, and
Nonwoven Fabrics Market Outlook to 2033 Projected High CAGR and Growth Opportunities
Nonwoven Fabrics Market Outlook to 2033 Projected High CAGR and Growth Opportuni …
A new report titled "Nonwoven Fabrics Market by Polymer Type (Polypropylene (PP), Polyethylene (PE), Polyethylene Terephthalate (PET), Wood Pulp, Rayon, and Others), Function (Disposables and Durables), Technology (Spunbond, Dry Laid, Air Laid, Wet Laid, Meltblown, and Others), and Application (Hygiene, Wipes, Medical, Filtration, Automotive, Building & Construction, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033" has been released by Allied Market Research. Key Highlights: - Market Size (2023): $58.4 Billion - Projected
Utilities Asset Management Market Poised for 11.3% CAGR Growth, Key Players, Market Size, Share, and Emerging Trends through 2031
Utilities Asset Management Market Poised for 11.3% CAGR Growth, Key Players, Mar …
According to the report published by Allied Market Research, the global utilities asset management market generated $4.3 billion in 2021, and is projected to reach $12.4 billion by 2031, growing at a CAGR of 11.3% from 2022 to 2031. The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape and regional landscape.

All 5 Releases


More Releases for PGD

Preimplantation Genetic Diagnostics (PGD) Market | ABBott Laboratories, Agilent …
The global preimplantation genetic diagnostics (pgd) market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the preimplantation genetic diagnostics (pgd) market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving
Preimplantation Genetics Diagnosis (PGD) Market Key Findings, Growth Strategy, T …
Preimplantation Genetics Diagnosis (PGD) Market - Overview The size of the preimplantation genetics diagnosis (PGD) market has been estimated to grow at a significant speed in the forthcoming years. This rapid growth in the market is on the basis of the high accuracy of the PGD in order to detect genetic disorders. In addition to this, increasing investment to detect genetic disorders along with chromosomal abnormalities around the world is also
Preimplantation Genetics Diagnosis (PGD) Market Current Scenario Trends, Compreh …
Preimplantation Genetics Diagnosis (PGD) Market - Overview The size of the preimplantation genetics diagnosis (PGD) market has been estimated to grow at a significant speed in the forthcoming years. This rapid growth in the market is on the basis of the high accuracy of the PGD in order to detect genetic disorders. In addition to this, increasing investment to detect genetic disorders along with chromosomal abnormalities around the world is also
Preimplantation Genetics Diagnosis (PGD) Market: Increasing Demand for Efficient …
The world PGD market is expected to witness notable growth in the coming years owning to the rising prevalence of genetic, hereditary and chromosomal diseases. Moreover, PGD have high chances of conceiving healthy embryos. However, the high costs incurred in the PGD technologies hamper the growth of the market. Moreover, stringent government regulations and ethical concerns also obstruct the growth of the market. In coming years, there would be increase
01-20-2020 | Health & Medicine
CRIFAX
Preimplantation Genetic Diagnosis (PGD) Market – Industry Growth Analysis & Fo …
CRIFAX added a report on ‘Preimplantation Genetic Diagnosis (PGD) Market Analysis Report, Global Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Netherlands, Russia, China, India, Japan, Australia, South Korea, Malaysia, Brazil, Mexico, Argentina, GCC, South Africa), Growth Potential, Competitive Market Share & Forecast, 2019 – 2028’to its database of market research collaterals consisting of overall market scenario with prevalent and future growth prospects, among other growth strategies used by key
Preimplantation Genetic Diagnosis Market : Asia PGD Market To Witness Highest Tr …
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the